Which T cells mediate allograft rejection?

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 2930916)

Published in Transplantation on September 01, 1985

Authors

D Steinmuller

Articles citing this

Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med (1987) 1.67

A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor. J Exp Med (1988) 1.61

Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med (1992) 1.37

Effector cells in allelic H-2 class I-incompatible skin graft rejection. J Exp Med (1987) 1.31

CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells. J Exp Med (2002) 1.16

T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest (1986) 0.98

Cellular requirements for renal allograft rejection in the athymic nude rat. J Exp Med (1989) 0.97

Evidence that the effector mechanism of skin allograft rejection is antigen-specific. Proc Natl Acad Sci U S A (1988) 0.96

Tumour-induced immunity to H-Y-disparate skin grafts without concomitant priming of CTL. Immunology (1990) 0.88

Rat heterotopic heart transplantation: quantification and analysis of cell mediated cytotoxicity. Clin Exp Immunol (1988) 0.86

Allograft rejection in athymic nude rats by transferred T-cell subsets. I. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to complete allogeneic incompatibilities. Immunology (1990) 0.86

An anti-CD103 immunotoxin promotes long-term survival of pancreatic islet allografts. Am J Transplant (2009) 0.81

Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens. Immunology (1993) 0.79

Corneal allograft rejection in bilateral penetrating keratoplasty: clinical and laboratory studies. Trans Am Ophthalmol Soc (1986) 0.77

Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation. Clin Epigenetics (2016) 0.75

Articles by these authors

(truncated to the top 100)

Cytotoxic properties of the eosinophil major basic protein. J Immunol (1979) 3.29

Immunization with skin isografts taken from tolerant mice. Science (1967) 2.05

Long-term follow-up after partial removal of a solitary kidney. N Engl J Med (1991) 1.99

Differential survival of skin and heart allografts in radiation chimaeras provides further evidence for Sk histocompatibility antigen. Nature (1974) 1.20

The survival of skin allografts and xenografts in germ-free mice. Transplantation (1972) 1.09

Cloned LYT-2+ cytolytic T lymphocytes destroy allogeneic tissue in vivo. J Exp Med (1984) 1.07

Passenger leukocytes and induction of allograft immunity. Transplant Proc (1971) 1.06

Transplantation biology and immunogenetics of murine skin-specific (Sk) alloantigens. Transplant Proc (1980) 0.98

Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study. Transplantation (1986) 0.94

The use of freshly explanted mouse epidermal cells for the in vitro induction and detection of cell-mediated cytotoxicity. Cell Immunol (1976) 0.89

Participation of H-2 regions in heart-transplant rejection. Transplantation (1976) 0.87

Allograft immunity produced with skin isografts from immunologically tolerant mice. Transplant Proc (1969) 0.86

Long-term results of renal transplantation in recipients with a functioning graft for 2 years. Transplantation (1982) 0.86

Differential survival of heart and skin allografts in inbred rats. Transplant Proc (1973) 0.86

In vitro and in vivo cytotoxicity of T cells cloned from rejecting allografts. Transplantation (1986) 0.84

Prolongation of rat heart allografts by donor pretreatment with immunosuppressive agents. Transplant Proc (1971) 0.84

Passenger leukocytes and the immunogenicity of skin allografts. J Invest Dermatol (1980) 0.84

Renal transplantation in the older recipient. J Urol (1985) 0.83

Alternative immunosuppressive strategies in the management of recipients of living related renal transplants. Transplant Proc (1989) 0.83

Effect of cyclosporine upon the function of ischemically damaged kidneys in the rat. Transplantation (1986) 0.82

Cross-species transplantation in embryonic and neonatal animals. Transplant Proc (1970) 0.82

Nonspecific tissue destruction as a consequence of cytotoxic T lymphocyte interaction with antigen-specific target cells. Transplant Proc (1987) 0.81

Skin grafting. Methods Enzymol (1984) 0.81

The older living renal donor: prognosis for the donor and recipient. J Urol (1980) 0.79

Renal transplantation for end-stage polycystic kidney disease. Urology (1987) 0.79

Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype. J Immunol (1981) 0.79

Prolonged survival of rat heart and kidney allografts irradiated in vitro. Transplantation (1971) 0.79

Lysis of mouse macrophages, fibroblasts, and epidermal cells by epidermal alloantigen-specific cytotoxic T lymphocytes: effect of culture and inflammatory agents on Epa-1 expression. Cell Immunol (1984) 0.79

Passenger leukocytes and the immunogenicity of skin allografts: a critical reevaluation. Transplant Proc (1981) 0.79

Late ureteral obstruction and hematuria from de novo angiosarcoma in a renal transplant patient. J Urol (1980) 0.79

Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. IV. An alloantigen shared with B cells but not T cells. Cell Immunol (1982) 0.78

Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programs. Transplant Proc (1981) 0.78

A reinvestigation of epidermal transplantation during chemical carcinogenesis. Cancer Res (1971) 0.78

Acute rejection of skin and heart allografts in rats matched at the major rat histocompatibility locus. Transplantation (1969) 0.78

The phenomenon of adaptation: graft or host? Transplant Proc (1973) 0.78

Functional capacity and rehabilitation of recipients with a functioning renal allograft for ten years or more. Transplantation (1983) 0.78

Blocking of interleukin-2 production, but not the tissue destruction induced by cytotoxic T cells, by cyclosporine. Transplantation (1989) 0.78

Improved results of cadaver renal transplantation with azathioprine, prednisone and antilymphoblast globulin. J Urol (1984) 0.78

Studies on immune lymphocyte transfer reactions in murine homologous cell chimeras. Transplantation (1970) 0.78

Establishment of cytolytic T lymphocyte clones to epidermal alloantigen Epa-1. Transplantation (1982) 0.78

Serum-blocking factors versus specific cellular tolerance in long-term survival of rat heart allografts. Transplantation (1976) 0.78

The "Sk" (skin-specific) rejection phenomenon as evidence of the natural role of acquired tolerance. Transplant Proc (1977) 0.77

Treatment of hereditary spherocytosis in Peromyscus by radiation and allogeneic bone marrow transplantation. Blood (1967) 0.77

Augmentation of cell-mediated cytotoxicity by short-term in vitro precultivation of effector cells. Transplant Proc (1979) 0.77

The outcome of renal transplantation in children without prolonged pre-transplant dialysis. Clin Pediatr (Phila) (1991) 0.77

Epidermal alloantigen and the survival of mouse skin allografts. Transplantation (1982) 0.76

Graft-versus-host reactions. Methods Enzymol (1984) 0.76

Renal computed tomography with 3-dimensional angiography and simultaneous measurement of plasma contrast clearance reduce the invasiveness and cost of evaluating living renal donor candidates. Transplantation (1996) 0.76

Renal transplantation in end stage renal disease patients with existing urinary diversion. J Urol (1986) 0.76

Nerve xenografts to apportion the role of axon and Schwann cell in myelinated fiber absence in hereditary sensory neuropathy, type II. Neurology (1979) 0.76

Suppressor cells and transplantation tolerance. Transplantation (1978) 0.76

Survival of neonatal mouse epidermal allografts. Transplantation (1990) 0.75

Management of end stage polycystic kidney disease with renal transplantation. J Urol (1981) 0.75

Survival of dog kidney allografts after in vitro irradiation. Transplantation (1973) 0.75

Comparative survival of transplanted heart and skin in inbred rats. Circulation (1970) 0.75

Failure to immunize specific pathogen-free BALB-c mice to C3Hf skin allografts with streptococcal antigen. Transplantation (1972) 0.75

The identification of lymphocyte phenotypes in peripheral blood of long-term renal allograft patients. Transplant Proc (1989) 0.75

The effect of incubation in vitro with triamcinolone acetonide on murine heart and skin allograft survival. Transplantation (1973) 0.75

Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes. J Immunol (1981) 0.75

Endoscopic correction of vesicoureteral reflux in the renal transplant candidate. J Urol (1989) 0.75

Reinnervation after orthotopic grafting of peripheral nerve segments in inbred rats. Plast Reconstr Surg (1974) 0.75

Determinants of allograft survival in 100 consecutive cadaver kidney transplants. J Urol (1982) 0.75

Survival of rat heart allografts irradiated in vitro. Surg Forum (1971) 0.75

Interlamellar corneal grafts in rats. Effect of histocompatibility. Arch Ophthalmol (1975) 0.75

Modifying the immunogenicity of cell membrane antigens. Tumors and transplants. Am J Clin Pathol (1975) 0.75

Two-color immunofluorescence flow cytometric analysis of lymphocytes in long-term renal allograft recipients. J Urol (1989) 0.75

Further studies on the use of mouse epidermal cells for the in vitro induction and detection of cell-mediated cytotoxicity. Cell Immunol (1979) 0.75

Brief communication: Effects of chronic cyclophosphamide and methotrexate treatment on skin allograft survival in mice and rats. J Natl Cancer Inst (1973) 0.75

Culturing before a transplant. Science (1981) 0.75

Pretransplant donor specific blood transfusions for one haplotype stimulatory mixed lymphocyte culture living related donor transplants. Am J Kidney Dis (1982) 0.75

Use of digital subtraction fluorography in screening for coronary artery disease in patients with chronic renal failure. Am J Kidney Dis (1989) 0.75

The relative effects of aztreonam versus gentamicin on nephrotoxicity induced by warm ischemia in the presence and absence of cyclosporine. Transplant Proc (1989) 0.75

Results of renal transplantation in children. J Urol (1980) 0.75

Rat heart allograft survival with donor pretreatment. Circulation (1971) 0.75

Evidence of skin-specific alloantigens in cell-mediated cytotoxicity reactions. Transplant Proc (1980) 0.75

Bone marrow transplantation in clinical hematology. Mayo Clin Proc (1982) 0.75

Behavior of skin allorafts in backcross progeny of tolerant males. J Natl Cancer Inst (1967) 0.75

Failure to confirm the prolonged survival of rat kidney allografts perfused with concanvalin A. Transplantation (1978) 0.75

Factors responsible for the differential survival of heart and skin allografts in inbred rats. Transplantation (1973) 0.75

Expression of I-region gene products on mouse tail epidermis cells. Cell Immunol (1979) 0.75

Monoclonal antibodies to tissue-restricted autoantigens in the mouse epidermis. Hybridoma (1988) 0.75

Regeneration following orthotopic peripheral nerve transplantation in inbred rats. Surg Forum (1973) 0.75

The role of computerized tomography in renal transplant patients. J Urol (1981) 0.75

Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. VI. Influence of the MHC on the tissue specificity of cytotoxic T-lymphocyte responses. Immunogenetics (1982) 0.75

Nondeletional mechanisms of tolerance in total-lymphoid irradiation-induced bone marrow chimeras. Transplantation (1993) 0.75

Lack of carcinogenic activity of 3-methyl-cholanthrene in the squirrel monkey. J Natl Cancer Inst (1969) 0.75

Prolonged kidney allograft survival in the (Lewis x BN)F1 to Lewis strain combination. Transplantation (1977) 0.75

Evidence of cell-mediated cytotoxicity to skin-specific alloantigens on mouse epidermal cells. Transplant Proc (1981) 0.75

Improved cadaver allograft survival in transfused recipients who remain serologically negative for cytomegalovirus. J Urol (1982) 0.75

Epidermal cells as targets and stimulators of allograft immunity in vitro. Transplant Proc (1977) 0.75

Clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in 40 recipient patients. Transplant Proc (1989) 0.75

Methods for induction of permanent graft survival. Transplant Proc (1979) 0.75

Preliminary clinical experience with pretransplant assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy (31P-MRS). Transplant Proc (1988) 0.75

Recent results of cadaver kidney retransplantation. J Urol (1989) 0.75

Prolonged survival of rats receiving kidney allografts perfused with concanavalin A. Transplantation (1976) 0.75

Lymphoid target cell replacement and refractoriness to graft-versus-host disease. Transplantation (1980) 0.75

Treatment of metastatic transitional cell carcinoma following renal transplantation. Cleve Clin J Med (1989) 0.75

Use of cyclosporine pharmacokinetic profiles in an antibody induction protocol reduces early acute rejection rates in recipients of primary cadaveric renal allografts. Transplant Proc (1997) 0.75

Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. II. Genetic basis of the response of C3H mice. J Immunol (1981) 0.75

A mouse is a murine but so is a rat, and related matters. Transplantation (1995) 0.75